GlaxoSmithKline Pharmaceuticals 관리
관리 기준 확인 3/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Bhushan Akshikar
최고 경영자
₹66.9m
총 보상
| CEO 급여 비율 | 21.7% |
| CEO 임기 | 1.9yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 2.1yrs |
| 이사회 평균 재임 기간 | 6.6yrs |
최근 관리 업데이트
Recent updates
GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 01
We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Can Manage Its Debt With Ease
Aug 29The GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 05Investors Appear Satisfied With GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Prospects As Shares Rocket 26%
Jun 01With EPS Growth And More, GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Makes An Interesting Case
May 05GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Popularity With Investors Is Clear
Apr 14Revenue Miss: GlaxoSmithKline Pharmaceuticals Limited Fell 5.9% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 15Is Now The Time To Put GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) On Your Watchlist?
Jan 18GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Investors Are Less Pessimistic Than Expected
Dec 28Here's Why We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Might Deserve Your Attention Today
Oct 05Is GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Using Too Much Debt?
Sep 12GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Has A Pretty Healthy Balance Sheet
Mar 17Does GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Have A Healthy Balance Sheet?
Sep 02GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Seems To Use Debt Rather Sparingly
Mar 02The GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Share Price Is Up 32% And Shareholders Are Holding On
Mar 20Does GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Have A Place In Your Dividend Portfolio?
Feb 27Declining Stock and Decent Financials: Is The Market Wrong About GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)?
Feb 06What Type Of Shareholders Make Up GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Share Registry?
Jan 11
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Shareholders Have Enjoyed A 26% Share Price Gain
Dec 06Earnings Miss: GlaxoSmithKline Pharmaceuticals Limited Missed EPS By 48% And Analysts Are Revising Their Forecasts
Nov 01Tread With Caution Around GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) 1.3% Dividend Yield
Oct 29What Kind Of Shareholders Hold The Majority In GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Shares?
Sep 29If You Had Bought GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Stock A Year Ago, You Could Pocket A 30% Gain Today
Aug 30Is GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Recent Performancer Underpinned By Weak Financials?
Aug 02It Might Not Be A Great Idea To Buy GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) For Its Next Dividend
Jul 12CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹7b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹67m | ₹15m | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹6b |
| Jun 30 2023 | n/a | n/a | ₹6b |
| Mar 31 2023 | ₹34m | ₹4m | ₹6b |
보상 대 시장: Bhushan 의 총 보상 ($USD 792.12K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 779.51K ).
보상과 수익: Bhushan 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Bhushan Akshikar
1.9yrs
테뉴어
₹66,885,000
보상
Mr. Bhushan Akshikar is Managing Director of GlaxoSmithKline Pharmaceuticals Limited from December 1, 2022. He served as Additional Director of GlaxoSmithKline Pharmaceuticals Limited since March 18, 2021...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD & Executive Director | 1.9yrs | ₹66.89m | 데이터 없음 | |
| Whole-Time Director & CFO | 2.6yrs | ₹68.92m | 데이터 없음 | |
| Executive Vice President of Human Resources | 3.9yrs | ₹37.40m | 데이터 없음 | |
| Vice President of Technology | less than a year | 데이터 없음 | 데이터 없음 | |
| VP of Administration & Real Estate and Company Secretary | no data | ₹11.57m | 데이터 없음 | |
| Executive Vice President of Legal | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Ethics & Compliance | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Communications & Government Affairs | 7.6yrs | 데이터 없음 | 데이터 없음 | |
| Executive Vice-President of Regulatory Affairs | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice-President of Adult Vaccines | 2.3yrs | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of General Medicines | 1.9yrs | 데이터 없음 | 데이터 없음 | |
| Commercial Head - Paediatric Vaccines | 1.8yrs | 데이터 없음 | 데이터 없음 |
2.1yrs
평균 재임 기간
경험이 풍부한 관리: GLAXO 의 관리팀은 경험 ( 2.1 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD & Executive Director | no data | ₹66.89m | 데이터 없음 | |
| Whole-Time Director & CFO | 2.6yrs | ₹68.92m | 데이터 없음 | |
| Non-Executive Chairperson | 5.6yrs | ₹3.25m | 데이터 없음 | |
| Independent Director | 2.5yrs | ₹2.65m | 데이터 없음 | |
| Non-Executive Independent Director | 15.3yrs | ₹2.70m | 데이터 없음 | |
| Non Executive Director | 7.6yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive Independent Director | 14.1yrs | ₹2.70m | 데이터 없음 | |
| Non-Executive Independent Director | 13yrs | ₹2.45m | 데이터 없음 | |
| Non-Executive & Independent Director | 4.5yrs | ₹2.45m | 데이터 없음 |
6.6yrs
평균 재임 기간
68.5yo
평균 연령
경험이 풍부한 이사회: GLAXO 의 이사회는 경험(평균 재직 기간 6.6 년)으로 간주됩니다.